Rational Combinations 360° Speakers
Ruslan Novosiadly, MD, PhD
Senior Research Advisor, Cancer Immunobiology, Biomarkers
Eli Lilly and Company
Ruslan Novosiadly, MD, PhD (currently Senior Research Advisor at Eli Lilly and Company, New York) is a translational scientist with 10+ years of academic/industrial experience and strong background in medical sciences, molecular/cell biology and translational (immuno)oncology. He received MD degree from Ivano-Frankivsk State Medical Academy (Ivano-Frankivsk, Ukraine) in 1999 followed by PhD degree in Biology from Georg-August University of Goettingen (Goettingen, Germany) in 2004.
Dr Novosiadly joined the Department of Medicine at Mount Sinai School of Medicine (New York City) in 2005 where he completed postdoctoral training followed by his appointment as Assistant Professor in 2009.
In 2009, Dr Novosiadly joined ImClone Systems, a wholly owned subsidiary of Eli Lilly, as Senior Scientist and Biology Lead for Cixutumumab (IGF-IR Antibody). In 2011, he was appointed as Director at the Department of Oncology – Translational Medicine where he led Cancer Signaling Biomarkers and Genetics Group. At present, Dr Novosiadly leads Experimental & Translational Immunooncology Group at the Department of Cancer Immunobiology.